Dextenza for Post-operative Treatment of Pterygium
- Conditions
- Pterygium of Both Eyes
- Interventions
- Drug: Intracanalicular Dexamethasone, (0.4 mg) Insert
- Registration Number
- NCT04351737
- Lead Sponsor
- Brandon Eye Associates, PA
- Brief Summary
DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation Compared to Standard of Care Topical Cortico-steroid Treatment in Patients who Undergo Bilateral Pterygium Surgery
- Detailed Description
In patients who undergo bilateral pterygium surgery, eyes will be randomized to receive either DEXTENZA at baseline, Month 1 and Month 2 or prednisolone x 3 months. Both eyes will receive antibiotic drops four times per day for two weeks and Maxitrol ointment at bedtime for two weeks following surgery.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
patients with bilateral pterygium -
none
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Pterygium patients Intracanalicular Dexamethasone, (0.4 mg) Insert patients with bilateral pterytium Pterygium patients Prednisolone Acetate patients with bilateral pterytium
- Primary Outcome Measures
Name Time Method Patient pain level follow pterygium removal 2 months measurement of pain following pterygium removal using the validated "Numeric Pain Rating Scale" to assess pain, which ranges from 0 to 10 with higher values indicating more severe pain.
inflammation 2 months measurement of ocular surface inflammation using the standard 1+ - 4+ rating scale commonly used in ophthalmology with 4+ indicating the most inflammation.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Brandon Eye Associates
🇺🇸Brandon, Florida, United States